$5.89 Billion is the total value of Hillhouse Capital Management's 45 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 14.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JD | Sell | JD COM INCspon adr cl a | $2,033,162,000 | -5.6% | 49,086,480 | -13.0% | 34.51% | -3.0% |
| BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $517,121,000 | -16.1% | 2,999,020 | -16.0% | 8.78% | -13.8% |
| WUBA | 58 COM INCspon adr rep a | $397,246,000 | +13.4% | 5,550,451 | 0.0% | 6.74% | +16.5% | |
| ESGR | ENSTAR GROUP LIMITED | $391,506,000 | -9.7% | 1,950,218 | 0.0% | 6.65% | -7.2% | |
| BGNE | BEIGENE LTDsponsored adr | $380,794,000 | -5.5% | 3,896,782 | 0.0% | 6.46% | -3.0% | |
| MDLZ | Sell | MONDELEZ INTL INCcl a | $304,868,000 | -8.2% | 7,123,081 | -12.8% | 5.18% | -5.7% |
| TAL | Buy | TAL ED GROUPsponsored ads | $260,069,000 | +114.7% | 8,753,599 | +143.6% | 4.42% | +120.6% |
| MLCO | MELCO RESORT ENTERTAINMENT Ladr | $259,227,000 | +20.4% | 8,926,546 | 0.0% | 4.40% | +23.7% | |
| SINA | Buy | SINA CORPord | $162,471,000 | +107.0% | 1,619,689 | +136.6% | 2.76% | +112.6% |
| NTES | NETEASE INCsponsored adr | $154,811,000 | +30.8% | 448,637 | 0.0% | 2.63% | +34.4% | |
| FGEN | Sell | FIBROGEN INC | $113,106,000 | -15.4% | 2,386,196 | -4.0% | 1.92% | -13.1% |
| SNAP | Buy | SNAP INCcl a | $109,361,000 | +23.2% | 7,485,341 | +22.6% | 1.86% | +26.5% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $103,195,000 | +147.3% | 1,368,449 | +128.5% | 1.75% | +154.3% |
| BEDU | BRIGHT SCHOLAR ED HLDGS LTDsponsored ads | $80,281,000 | -19.6% | 4,300,000 | 0.0% | 1.36% | -17.4% | |
| YY | YY INC | $60,929,000 | +30.3% | 538,906 | 0.0% | 1.03% | +33.8% | |
| TRIP | Buy | TRIPADVISOR INC | $56,447,000 | -14.7% | 1,638,057 | +0.3% | 0.96% | -12.4% |
| MOMO | New | MOMO INCadr | $53,206,000 | – | 2,173,457 | +100.0% | 0.90% | – |
| CBPO | CHINA BIOLOGIC PRODS HLDGS I | $48,711,000 | -14.6% | 618,391 | 0.0% | 0.83% | -12.3% | |
| VIPS | VIPSHOP HLDGS LTDsponsored adr | $46,288,000 | +33.3% | 3,949,523 | 0.0% | 0.79% | +36.9% | |
| APLS | New | APELLIS PHARMACEUTICALS INC | $31,000,000 | – | 1,428,571 | +100.0% | 0.53% | – |
| XLRN | ACCELERON PHARMA INC | $29,708,000 | +13.7% | 700,000 | 0.0% | 0.50% | +16.7% | |
| TWTR | TWITTER INC | $26,867,000 | +42.3% | 1,119,000 | 0.0% | 0.46% | +46.2% | |
| NFLX | Buy | NETFLIX INC | $23,553,000 | +94.7% | 122,700 | +84.0% | 0.40% | +100.0% |
| LBTYK | Sell | LIBERTY GLOBAL PLC | $22,248,000 | -10.8% | 657,444 | -13.8% | 0.38% | -8.3% |
| KANG | IKANG HEALTHCARE GROUP INCsponsored adr | $19,921,000 | +17.2% | 1,260,798 | 0.0% | 0.34% | +20.3% | |
| MYOK | Buy | MYOKARDIA INC | $19,745,000 | +139.7% | 469,000 | +144.0% | 0.34% | +146.3% |
| BRKA | BERKSHIRE HATHAWAY INC DELcl a | $19,046,000 | +8.3% | 64 | 0.0% | 0.32% | +11.0% | |
| SCHW | SCHWAB CHARLES CORP NEW | $17,455,000 | +17.4% | 339,782 | 0.0% | 0.30% | +20.3% | |
| CHTR | CHARTER COMMUNICATIONS INC Ncl a | $16,665,000 | -7.6% | 49,603 | 0.0% | 0.28% | -5.0% | |
| LN | LINE CORPsponsored adr | $13,805,000 | +13.2% | 336,800 | 0.0% | 0.23% | +16.4% | |
| AMZN | AMAZON COM INC | $13,521,000 | +21.6% | 11,562 | 0.0% | 0.23% | +25.0% | |
| VRSN | VERISIGN INC | $13,420,000 | +7.6% | 117,264 | 0.0% | 0.23% | +10.7% | |
| MCO | MOODYS CORP | $13,277,000 | +6.0% | 89,949 | 0.0% | 0.22% | +8.7% | |
| TIG | TIGENIXsponsored ads | $11,052,000 | -4.3% | 483,870 | 0.0% | 0.19% | -1.6% | |
| SPGI | S&P GLOBAL INC | $9,857,000 | +8.4% | 58,187 | 0.0% | 0.17% | +11.3% | |
| CCJ | CAMECO CORP | $9,467,000 | -4.6% | 1,025,700 | 0.0% | 0.16% | -1.8% | |
| GTHX | G1 THERAPEUTICS INC | $8,928,000 | -20.3% | 450,000 | 0.0% | 0.15% | -17.8% | |
| SFUN | FANG HLDGS LTDadr | $8,370,000 | +37.8% | 1,500,000 | 0.0% | 0.14% | +42.0% | |
| CLSD | Buy | CLEARSIDE BIOMEDICAL INC | $6,609,000 | -16.0% | 944,202 | +4.9% | 0.11% | -13.8% |
| IDXX | IDEXX LABS INC | $6,525,000 | +0.6% | 41,725 | 0.0% | 0.11% | +3.7% | |
| PTI | PROTEOSTASIS THERAPEUTICS IN | $5,048,000 | +177.7% | 865,923 | 0.0% | 0.09% | +186.7% | |
| NABRIVA THERAPEUTICS PLC | $4,797,000 | -27.0% | 802,174 | 0.0% | 0.08% | -25.7% | ||
| TSRO | TESARO INC | $3,074,000 | -35.8% | 37,100 | 0.0% | 0.05% | -34.2% | |
| PCLN | Sell | PRICELINE GRP INC | $2,375,000 | -98.8% | 1,367 | -98.8% | 0.04% | -98.8% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $1,786,000 | -33.9% | 203,915 | -11.7% | 0.03% | -33.3% |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -130,000 | -100.0% | -0.03% | – |
| RYB | Exit | RYB ED INCadr | $0 | – | -430,000 | -100.0% | -0.20% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -1,000,000 | -100.0% | -0.26% | – |
| BITA | Exit | BITAUTO HLDGS LTDsponsored ads | $0 | – | -1,124,017 | -100.0% | -0.83% | – |
| SOHU | Exit | SOHU COM INC | $0 | – | -1,650,727 | -100.0% | -1.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MONDELEZ INTL INC | 22 | Q3 2018 | 44.4% |
| JD COM INC | 19 | Q2 2019 | 80.2% |
| SOHU COM INC | 19 | Q1 2018 | 13.4% |
| 58 COM INC | 18 | Q3 2018 | 7.8% |
| TAL EDUCATION GROUP | 18 | Q2 2019 | 4.4% |
| CTRIP COM INTL LTD | 17 | Q2 2017 | 28.4% |
| BEIGENE LTD | 14 | Q2 2019 | 25.2% |
| MELCO RESORT ENTERTAINMENT L | 14 | Q3 2018 | 6.4% |
| CAMECO CORP | 14 | Q4 2017 | 2.2% |
| ENSTAR GROUP LIMITED | 12 | Q2 2019 | 21.9% |
View Hillhouse Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| China Jo-Jo Drugstores Holdings, Inc. | February 14, 2023 | 403,334 | 4.7% |
| TScan Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Enfusion, Inc. | February 14, 2022 | 4,975,183 | 7.6% |
| Enstar Group LTD | July 19, 2021 | ? | ? |
| Zoom Video Communications, Inc. | February 16, 2021 | 2,981,265 | 1.5% |
| NIO Inc. | February 14, 2020 | ? | ? |
| Sea Ltd | February 14, 2020 | 4,300,000 | 2.3% |
| Uxin Ltd | February 14, 2020 | 21,733,023 | 2.6% |
| Apellis Pharmaceuticals, Inc. | February 14, 2019 | 2,098,581 | 3.7% |
| iQIYI, Inc. | February 14, 2019 | 240,191,174 | 11.0% |
View Hillhouse Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-03-05 |
| 13F-NT | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 4 | 2024-02-01 |
| 3 | 2024-01-25 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
View Hillhouse Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.